摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-butyl-2-isopropylimidazole | 46029-32-7

中文名称
——
中文别名
——
英文名称
1-butyl-2-isopropylimidazole
英文别名
1-n-Butyl-2-isopropylimidazol;1-butyl-2-isopropyl-1H-imidazole;1-Butyl-2-(1-methylethyl)-1H-imidazole;1-butyl-2-propan-2-ylimidazole
1-butyl-2-isopropylimidazole化学式
CAS
46029-32-7
化学式
C10H18N2
mdl
——
分子量
166.266
InChiKey
RXLXNBNZCYSWPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1-butyl-2-isopropylimidazole二氯甲烷 为溶剂, 反应 18.0h, 生成 1-butyl-2-isopropyl-3-methylimidazolium triflimide
    参考文献:
    名称:
    Grignard Reactions in Imidazolium Ionic Liquids
    摘要:
    A new, base-stable, imidazolium room-temperature ionic liquid (RTIL) has been prepared and applied to the addition of Grignard reagents to carbonyl compounds. These reactions occur readily at ambient temperature to afford the alcohol products in good to excellent yield. The RTIL can be recycled and reused numerous times without any difficulty.
    DOI:
    10.1021/jo060536o
  • 作为产物:
    描述:
    2-异丙基咪唑正溴丁烷sodium hydroxide四丁基碘化铵 作用下, 以 甲苯 为溶剂, 反应 20.0h, 以98%的产率得到1-butyl-2-isopropylimidazole
    参考文献:
    名称:
    Grignard Reactions in Imidazolium Ionic Liquids
    摘要:
    A new, base-stable, imidazolium room-temperature ionic liquid (RTIL) has been prepared and applied to the addition of Grignard reagents to carbonyl compounds. These reactions occur readily at ambient temperature to afford the alcohol products in good to excellent yield. The RTIL can be recycled and reused numerous times without any difficulty.
    DOI:
    10.1021/jo060536o
点击查看最新优质反应信息

文献信息

  • Niobium(<scp>v</scp>) chloride and imidazolium bromides as efficient dual catalyst systems for the cycloaddition of carbon dioxide and propylene oxide
    作者:Michael E. Wilhelm、Michael H. Anthofer、Robert M. Reich、Valerio D'Elia、Jean-Marie Basset、Wolfgang A. Herrmann、Mirza Cokoja、Fritz E. Kühn
    DOI:10.1039/c3cy01057k
    日期:——
    The application of niobium(V) chloride and several imidazolium bromides as catalyst systems for the cycloaddition of propylene oxide (PO) with carbon dioxide to propylene carbonate (PC) is reported. A set of 31 different imidazolium bromides has been synthesized with varying substituents at all five imidazolium ring atoms, of which 17 have not been reported before. The impact of different substitution
    据报道,(V)和几种咪唑化物作为催化剂将环氧丙烷(PO)与二氧化碳环加成成碳酸丙酯(PC)。合成了31种不同的咪唑化物,它们在所有5个咪唑鎓环原子上都有不同的取代基,其中17种以前从未报道过。研究了咪唑环上不同取代方式(空间和电子变化以及在PO中的溶解度)对催化活性的影响。催化剂结构的优化允许在温和的反应条件下以高的反应速率以非常好的收率和对PC的选择性来平衡二氧化碳的价位。
  • TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
    申请人:Babu Srinivasan
    公开号:US20110201593A1
    公开(公告)日:2011-08-18
    The invention provides novel compounds of formula I having the general formula: wherein R 1 , R 2 , R 3 , X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.
    本发明提供了具有以下一般式的新化合物I: 其中R1、R2、R3、X和Y如本文所述。因此,这些化合物可以在药学上可接受的组合物中提供,并用于治疗免疫或过度增生性疾病。
  • A new class of unique quinoidal-like imidazoliumyl tetrazinides: synthesis, structure, and mechanism
    作者:Yanxue Geng、Weijun Sun、Weixu Zhang、Mengyao Li、Guo Wang、Jianchun Wang
    DOI:10.1039/d3nj04766k
    日期:——
    5-substituted-1H-imidazol-3-ium-3-yl)-3,6-dihydro-1,2,4,5-tetrazin-3-ides (3a–3z, 3aa–3ak) was synthesized with medium to good yield by the reaction of 3,6-dichloro-1,2,4,5-tetrazine with a variety of substituted imidazoles in the presence of trace water in solvents. The quinoidal-like structure of these compounds was demonstrated via spectroscopic methods, X-ray diffraction techniques, and computational chemistry
    一系列 6-氧代-3-(1,2,4,5-取代-1H-咪唑-3-鎓-3-基)-3,6-二氢-1,2,4,5-四嗪- 3,6-二-1,2,4,5-四嗪与多种取代咪唑在微量存在下反应合成了3- ides ( 3a–3z , 3aa–3ak ),收率中等至良好在溶剂中。这些化合物的醌状结构通过光谱方法、X 射线衍射技术和计算化学得到了证明。此外,使用- 18 O通过高分辨率质谱(HRMS)证明四嗪酮中的氧来自溶剂中的。此外,还提出了芳香族亲核取代的可能机制。
查看更多